3 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 3 |
| Phase 2 | 1 | Recruiting 1 |
Follow BPDCN: new trials by email Literature Review of BPDCN trials Research Report on BPDCN
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CARCIK CD123/33 for Refractory/Relapsed AML and BPDCN in Children and Adults CARCIK CD123/33 infusion - AML (Acute Myeloid Leukemia), BPDCN | Phase 1 / Phase 2 | Recruiting | Fondazione Matilde Tettamanti Menotti De Marchi Onlus | 18 | 2026-10-01 | 2026-10-16 |
| Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies Tagraxofusp, Fludarabine, Cytarabine - Hematologic Malignancy, AML | Phase 1 | Recruiting | Therapeutic Advances in Childhood Leukemia Consortium | 54 | 2022-11-11 | 2024-12-06 |
| CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) CD123-CAR T, Cyclophosphamide, Fludarabine - AML/MDS, B-ALL | Phase 1 | Recruiting | St. Jude Children's Research Hospital | 108 | 2020-07-29 | 2026-05-19 |
Blastic Plasmacytoid Dendritic Cell Neoplasm (3) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, B-Cell (1) · Lymphoma, T-Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Histiocytic Disorders, Malignant (3) · Leukemia (3) · Lymphoma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Skin Diseases (3) · Skin Neoplasms (3) · Skin and Connective Tissue Diseases (3) · Hematologic Neoplasms (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia, Lymphoid (2)
fludarabine (2) · Azacitidine (1) · Calcium Dobesilate (1) · Cyclophosphamide (1) · Cytarabine (1) · Dexamethasone (1) · Hydrocortisone (1) · Mesna (1) · Methotrexate (1) · Rituximab (1) · Vincristine (1) · fludarabine phosphate (1) · tagraxofusp (1)
Fondazione Matilde Tettamanti Menotti De Marchi Onlus (1) · St. Jude Children's Research Hospital (1) · Therapeutic Advances in Childhood Leukemia Consortium (1)
United States (2) · Australia (1) · Italy (1)
Adam Lamble, MD (1) · Paulina Velasquez, MD (1) · Swati Naik, MD (1)
2025 (1)